DV
Dividend Vision

PYPD Stock — PolyPid

PolyPid (PYPD)

Updated October 16, 2026.

PYPD is a Stock. Total return is -99.2% over the past 6.3 years, 276.1 points behind SPY at 176.9%.

PolyPid is a biopharmaceutical company developing targeted, locally administered therapeutics using its proprietary polymer-lipid encapsulation technology. Its lead program, D-PLEX100, is in Phase 3 testing for prevention of surgical site infections in colorectal surgery patients, with additional programs in preclinical and early-stage development for cancer treatment. The company does not currently have an established distribution program.

PYPD performance versus SPY

Price and return data through 2026-10-16.

Total return is -99.2% over the past 6.3 years, 276.1 points behind SPY at 176.9%. Over the past year its total return — price change plus distributions reinvested — is 40.9%. Its deepest 1-year drawdown was 33.0%.

WindowTotal returnCAGR
1M-9.4%—
3M-9.1%—
6M1.3%—
YTD8.8%—
1Y40.9%—
2Y CAGR—17.30%
3Y CAGR—6.50%
5Y CAGR—-53.80%
Since inception (6.3 years)-99.2%-53.20%

PYPD key facts

Asset type
Stock
Asset class
Equity
Inception date
06/26/2020
Distribution frequency
None
Last close
$4.72 (as of 2026-10-16)
Market cap
$95,871,536
Average volume
150478.0
Beta
1.379
Payout ratio
0.0%
EPS
$-1.48

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PYPD risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 33.0%.

Who may consider PYPD — and who may not

It is a weaker fit for investors who need monthly cash flow (PYPD does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PYPD

Tagged: Healthcare.

Frequently asked questions

Does PYPD pay monthly?

No. PYPD does not currently distribute.

When does PYPD pay a dividend?

PYPD does not currently distribute.

How has PYPD performed?

Total return is -99.2% over the past 6.3 years, 276.1 points behind SPY at 176.9%. Over the past year its total return — price change plus distributions reinvested — is 40.9%. Its deepest 1-year drawdown was 33.0%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.